Cancer Biomarkers Market Size to Worth Around $ 28.2 billion

-

The global cancer biomarkers market is experiencing significant growth and is projected to reach USD 28.2 billion by 2026, up from USD 12.4 billion in 2021, with a compound annual growth rate (CAGR) of 17.7%. This surge in growth can be attributed to several key factors, including the rising prevalence of cancer worldwide, increasing use of cancer biomarkers in drug discovery and development, and ongoing research and development efforts in the field of cancer biomarkers. Emerging markets such as India and Japan also offer lucrative opportunities for market players operating in this space.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202

Market Segmentation and Trends

Biomarker Type

The cancer biomarkers market is divided into three main segments based on biomarker type: protein, genetic, and other cancer biomarkers. In 2020, the protein biomarkers segment accounted for the largest market share, primarily due to ongoing technological advancements in the development of cancer biomarkers and increasing investment in research and development (R&D) activities.

Cancer Type

The market is also segmented based on cancer type, including breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-Hodgkin's lymphoma, kidney, and other cancer types. The breast cancer segment held the largest market share in 2020, owing to the high incidence of breast cancer globally and increased utilization of cancer biomarkers in drug discovery and development. However, the lung cancer segment is expected to register the highest growth rate during the forecast period.

Profiling Technology

By profiling technology, the market is divided into omics technologies, imaging technologies, immunoassay, bioinformatics, and cytogenetics. In 2020, omics technology accounted for the largest market share, driven by the use of cancer biomarkers in drug discovery and development and ongoing R&D efforts in the field.

Application

The cancer biomarkers market is segmented based on application into diagnostics, research and development, prognostics, risk assessment, and other applications. In 2020, the diagnostics segment held the largest market share, mainly due to the increasing incidence of cancer worldwide and the rising use of cancer biomarkers in drug discovery and development.

Regional Insights

North America dominated the global cancer biomarkers market in 2020, driven by technological advancements in the development of cancer biomarkers, the high incidence of cancer, and increased use of biomarkers in drug discovery and development. Europe and the Asia Pacific regions also represent significant markets for cancer biomarkers, with the Asia Pacific region expected to exhibit the highest growth rate during the forecast period due to an increase in R&D activities and expanding healthcare infrastructure.

Key Market Players

The global cancer biomarkers market is highly competitive and comprises several leading players, including:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Thermo Fisher Scientific, Inc. (US)
  • QIAGEN N.V. (Netherlands)
  • Illumina, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Abbott Laboratories (US)
  • bioMérieux SA (US)
  • Becton, Dickinson and Company (US)
  • Merck Millipore (US)
  • Agilent Technologies (US)
  • Myriad Genetics, Inc. (US)
  • Sysmex Corporation (Japan)
  • Hologic, Inc. (US)
  • Quest Diagnostics (US)

These players continue to innovate and develop cutting-edge cancer biomarker solutions, ensuring the market remains dynamic and competitive.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=202

Conclusion

The global cancer biomarkers market is poised for substantial growth in the coming years, fueled by advancements in technology, increased research funding, and a growing need for personalized medicine. As the world seeks better diagnostic and prognostic tools for managing cancer, the importance of cancer biomarkers will continue to grow.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in their ow
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d
Read more

Stable Isotope Labeled Compounds Market Growth: Trends and Opportunities

-
The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0% between 2019 and 2024. The growth of this market is driven majorly by the increase in research activities in the pharmaceutical and biotechnology sector, the rising prevalence of cancer, and rising proteomics research. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The H-2 labeled compounds segment accounted for the largest share of the stable isotope labeled compounds market. Based on type, the stable isotope labeled compounds industry is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest share of the stable isotope-labeled compounds market in 2019. The large share of this
Read more